Stock MITRA MITHRA PHARMACEUTICALS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Mithra Pharmaceuticals S.A.

Equities

MITRA

BE0974283153

Real-time Euronext Bruxelles
Other stock markets
 11:35:26 2024-04-26 am EDT 		5-day change 1st Jan Change
0.216 EUR -1.82% Intraday chart for Mithra Pharmaceuticals S.A. -3.57% -82.78%
Apr. 22 Mithra Pharmaceuticals Obtains Court Protection Measures MT
Mar. 08 Mithra Pharmaceuticals SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Mithra updates on offers received in the context of its monetization process and on its Annual Report 2023
GL
Mithra secures court protection measures to advance monetization process
GL
Early data from Mithra's ESTELLE pediatric study to be presented at two upcoming congresses
AQ
Mithra Pharmaceuticals S A : reaches milestone in estetrol skin study
PU
Mithra reports full year 2023 financial results
GL
Mithra announces changes to its executive management
AQ
Mithra announces changes to its executive management
GL
Mithra announces changes to its executive management
AQ
Mithra initiates monetization process, receives bridge loan from existing lenders
GL
Mithra - DONESTA safety study for menopause completes treatment phase and advances to data management and reporting phase
AQ
DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase
GL
Mithra sells shares in Mayne Pharma
GL
Mithra Announces its 2024 Financial Calendar
AQ
Mithra updates on cash position
GL
Mithra updates on cash position
AQ
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025
AQ
Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA in Israel
AQ
Mithra Pharmaceuticals S A : Publication of a transparency notification received from The Goldman Sachs Group Inc.
PU
Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel
GL
Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MITRA Stock
  4. News Mithra Pharmaceuticals S.A.
  5. Press Releases